RecruitingPhase 2NCT06852820

68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)

Studying Leukoencephalopathy with calcifications and cysts

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Melissa Lumish
Principal Investigator
Melissa Lumish, MD
Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center
Intervention
Lu-PSMA-617(drug)
Enrollment
10 enrolled
Eligibility
18 years · All sexes
Timeline
20262027

Study locations (1)

Collaborators

Novartis

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06852820 on ClinicalTrials.gov

Other trials for Leukoencephalopathy with calcifications and cysts

Additional recruiting or active studies for the same condition.

See all trials for Leukoencephalopathy with calcifications and cysts

← Back to all trials